With the Medicare Access and CHIP Reauthorization Act (MACRA) set to take effect January 1, 2017, The American Journal of Managed Care has created a resource center, the MACRA Compendium, where payers and providers can find updates on the transition to value-based care.
FOR IMMEDIATE RELEASEDecember 22, 2016
PLAINSBORO, N.J.—If you still don’t understand the Medicare Access and CHIP Reauthorization Act (MACRA), you’re not alone. While small practices have the greatest learning curve, even larger health systems may benefit from a convenient source of information on the 2015 law, which takes effect January 1, 2017.
With that in mind, The American Journal of Managed Care (AJMC) has created the MACRA Compendium, a resource center on www.ajmc.com that brings together news, commentary, and multimedia content on the law, which pushes Medicare’s transition from fee-for-service to value-based payment. You can find the center at http://www.ajmc.com/compendium/macra.
The MACRA Compendium features content from:
· The fall meeting of AJMC’s ACO & Emerging Healthcare Delivery Coalition, which discussed how accountable care organizations have laid the groundwork for MACRA.
· Commentary from several AJMC contributors, including Greg Fulton of Philips Wellcentive and heath information technology strategist Mark Heaney.
· Video interviews with CMS’ Kate Goodrich, MD, on how physicians can successfully adapt to the Merit-Based Incentive Payment System.
To contribute commentary to the MACRA Compendium, contact Editorial Director Nicole Beagin at (609) 716-7777 x 131.
About the Journals and AJMC.com
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
,
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More